Patents by Inventor Resat Cinar
Resat Cinar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11939297Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: GrantFiled: February 10, 2023Date of Patent: March 26, 2024Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20230219896Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: February 10, 2023Publication date: July 13, 2023Applicant: The USA, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20230202983Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: September 29, 2022Publication date: June 29, 2023Applicant: The USA, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Patent number: 11485709Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: GrantFiled: May 8, 2020Date of Patent: November 1, 2022Assignee: The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Patent number: 11155521Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold and (ii) a second therapeutic scaffold.Type: GrantFiled: March 4, 2016Date of Patent: October 26, 2021Assignee: The United States of America as represented by the Secretary, Department of Health and Human ServicesInventors: Resat Cinar, George Kunos, Malliga R. Iyer, William A. Gahl, Bernadette R. Gochuico, May Christine Vergara Malicdan
-
Publication number: 20200331861Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: May 8, 2020Publication date: October 22, 2020Applicant: The USA, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Patent number: 10787419Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: GrantFiled: August 10, 2017Date of Patent: September 29, 2020Assignee: The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Patent number: 10683270Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: GrantFiled: August 10, 2017Date of Patent: June 16, 2020Assignee: The United States of America as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20190352268Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: June 12, 2019Publication date: November 21, 2019Applicant: The USA, as represented by the Secretary, Department of Health & Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar
-
Patent number: 10329259Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X and Y are each independently selected from optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted cycloalkyl, optionally-substituted heterocycloalkyl, or optionally-substituted alkyl; Q is H, hydroxyl, or optionally-substituted alkoxy; R1, R2, and R3 are each independently selected from H, optionally-substituted alkyl, optionally-substituted cycloalkyl, halogen, cyano, nitro, hydroxy, optionally-substituted alkoxy, amino, aminocarbonyl, optionally-substituted sulfonyl, optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted carboxyl, acyl, optionally-substituted alkenyl, optionally-substituted alkynyl, optionally-substituted phosphonyl, optionally-substituted phosphinyl, aralkyl, optionally-substituted thiol, or R2 and R3 together with Z form an optionally-substituted cycloalkyl ring or an optionally-substituted heterocycloalkyl ring; Z is BType: GrantFiled: May 8, 2015Date of Patent: June 25, 2019Assignee: The United States of America, as represented by the Secretary, Department of Health & Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20180273485Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: June 1, 2016Publication date: September 27, 2018Applicant: The United States of America, as represented by the Secretary, Department of Health and Human ServInventors: George Kunos, Malliga Iyer, Resat Cinar
-
Publication number: 20180179163Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X and Y are each independently selected from optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted cycloalkyl, optionally-substituted heterocycloalkyl, or optionally-substituted alkyl; Q is H, hydroxyl, or optionally-substituted alkoxy; R1, R2, and R3 are each independently selected from H, optionally-substituted alkyl, optionally-substituted cycloalkyl, halogen, cyano, nitro, hydroxy, optionally-substituted alkoxy, amino, aminocarbonyl, optionally-substituted sulfonyl, optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted carboxyl, acyl, optionally-substituted alkenyl, optionally-substituted alkynyl, optionally-substituted phosphonyl, optionally-substituted phosphinyl, aralkyl, optionally-substituted thiol, or R2 and R3 together with Z form an optionally-substituted cycloalkyl ring or an optionally-substituted heterocycloalkyl ring; ZType: ApplicationFiled: May 8, 2015Publication date: June 28, 2018Inventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20180022705Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: August 10, 2017Publication date: January 25, 2018Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20180022706Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: August 10, 2017Publication date: January 25, 2018Applicant: The United States of America as represented by the Secretary Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Patent number: 9765031Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: GrantFiled: November 12, 2013Date of Patent: September 19, 2017Assignee: The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
-
Publication number: 20160257654Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold and (ii) a second therapeutic scaffold.Type: ApplicationFiled: March 4, 2016Publication date: September 8, 2016Applicant: The United States of America, as represented by the Secretary, Department of Health and Human ServInventors: Resat Cinar, George Kunos, Malliga R. Iyer, William A. Gahl, Bernadette R. Gochuico, May Christine Vergara Malicdan
-
Publication number: 20160039766Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.Type: ApplicationFiled: November 12, 2013Publication date: February 11, 2016Applicant: The United States of America, as represented by th e Secretary, Department of Health and Human ServiInventors: George Kunos, Malliga Iyer, Resat Cinar, Kenner C. Rice
